The role of glutamatergic function in the pathophysiology of treatment resistant schizophrenia and the potential of novel treatment targeting it

Project: Research

Project Details

StatusActive
Effective start/end date1/01/202231/12/2024

Collaborative partners

Funding

  • MRC Medical Research Council: £1,047,961.00